Kilitch Drugs (India) Ltd: Financial Statements & Historical Data

COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 9 October 2026, 8:57 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price242₹ per share

Reported P/E28.2Times

Book value per share80.0₹ per share

Reported ROCE13.4 %%

Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Financial changes explained

Automatically calculated historical comparisons. Amounts are in ₹ crore unless stated otherwise. These summaries describe reported figures and do not rate or recommend the shares.

Reporting coverage: Quarterly: Jun 2026 · Annual: Mar 2026 · Cash flow: Mar 2026 · Balance sheet: Mar 2026.

Quarterly revenue change

Quarterly revenue was ₹44.88 crore in Jun 2026, compared with ₹43.14 crore in Jun 2025. The change was an increase of ₹1.74 crore. Year-on-year change: +4.0%.

Calculation and source

Absolute change = later amount − earlier amount. Percentage change = (later ÷ earlier − 1) × 100.

Basis: consolidated. Period: 2025-06 to 2026-06.

View the financial table · Data source

Quarterly net result change

Quarterly net result was ₹1.96 crore in Jun 2026, compared with ₹2.27 crore in Jun 2025. The change was a decrease of ₹0.31 crore. Year-on-year change: -13.7%.

Calculation and source

Absolute change = later amount − earlier amount. Percentage change = (later ÷ earlier − 1) × 100.

Basis: consolidated. Period: 2025-06 to 2026-06.

View the financial table · Data source

Annual revenue change

Annual revenue was ₹235.00 crore in Mar 2026, compared with ₹198.00 crore in Mar 2025. The change was an increase of ₹37.00 crore. Year-on-year change: +18.7%.

Calculation and source

Absolute change = later amount − earlier amount. Percentage change = (later ÷ earlier − 1) × 100.

Basis: consolidated. Period: 2025-03 to 2026-03.

View the financial table · Data source

Annual net result change

Annual net result was ₹30.00 crore in Mar 2026, compared with ₹25.00 crore in Mar 2025. The change was an increase of ₹5.00 crore. Year-on-year change: +20.0%.

Calculation and source

Absolute change = later amount − earlier amount. Percentage change = (later ÷ earlier − 1) × 100.

Basis: consolidated. Period: 2025-03 to 2026-03.

View the financial table · Data source

Quarterly net profit margin

Calculated net profit margin moved from 5.26% in Jun 2025 to 4.37% in Jun 2026: 0.89 percentage points lower.

Calculation and source

Margin = net profit ÷ revenue × 100. Margin change is measured in percentage points; rounded source figures can affect the result.

Basis: consolidated. Period: 2025-06 to 2026-06.

View the financial table · Data source

Eight-quarter revenue comparison

Revenue across the four quarters ending Jun 2026 totalled ₹237.21 crore, compared with ₹208.01 crore across the preceding four quarters. The change was 14.0%.

Calculation and source

Sum four consecutive quarters and compare with the preceding four non-overlapping quarters. All eight observations must exist.

Basis: consolidated. Period: 2024-09 to 2026-06.

View the financial table · Data source

Profit and operating cash flow

For Mar 2026, operating cash flow was ₹24.00 crore and net profit was ₹30.00 crore. Operating cash flow ÷ net profit was 0.80 times.

Calculation and source

These are different accounting measures. The ratio, when shown, uses the same reporting period and accounting basis; it is not an earnings-quality rating.

Basis: consolidated. Period: 2026-03.

View the financial table · Data source

Net profit history

Net profit was positive in 5 of 5 available annual observations in the five-year window ending Mar 2026.

Calculation and source

Count observations greater than zero. Missing years are excluded from both counts. Zero is not counted as positive.

Basis: consolidated. Period: 2022-03 to 2026-03.

View the financial table · Data source

Operating cash flow history

Operating cash flow was positive in 4 of 5 available annual observations in the five-year window ending Mar 2026.

Calculation and source

Count observations greater than zero. Missing years are excluded from both counts. Zero is not counted as positive.

Basis: consolidated. Period: 2022-03 to 2026-03.

View the financial table · Data source

Reported borrowings change

Reported borrowings was ₹89.00 crore in Mar 2026, compared with ₹49.00 crore in Mar 2025. The change was an increase of ₹40.00 crore. Year-on-year change: +81.6%.

Calculation and source

Absolute change = later amount − earlier amount. Percentage change = (later ÷ earlier − 1) × 100.

Basis: consolidated. Period: 2025-03 to 2026-03.

View the financial table · Data source

Promoters ownership share

Reported Promoters ownership moved from 63.77% in Mar 2026 to 63.77% in Jun 2026, a change of 0.00 percentage points.

Calculation and source

Later ownership percentage − earlier percentage. Ownership proportions do not establish purchases or sales; changes in share capital can also affect them.

Basis: Issuer ownership; separately refreshed. Period: 2026-03 to 2026-06.

View the financial table · Data source

FIIs ownership share

Reported FIIs ownership moved from 0.00% in Mar 2026 to 0.12% in Jun 2026, a change of +0.12 percentage points.

Calculation and source

Later ownership percentage − earlier percentage. Ownership proportions do not establish purchases or sales; changes in share capital can also affect them.

Basis: Issuer ownership; separately refreshed. Period: 2026-03 to 2026-06.

View the financial table · Data source

Summary generated: 10 Oct 2026, 19:32 IST. Figures may be rounded, delayed or restated. Comparisons follow the source’s annual and quarterly classifications; changes in reporting duration or accounting policies can limit comparability. Check original filings. No cause for a change is inferred from arithmetic alone.

Stored market and accounting figures

Price record: 9 October 2026, 8:57 pm +05:30. Not a live quote.

Measure	Stored figure
Market Cap	847 Cr.
Current Price	242
High / Low	268/117
Stock P/E	28.2
Book Value	80.0
Dividend Yield	0.00 %
ROCE	13.4 %
ROE	10.6 %
Face Value	10.0

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Competitors

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Kilitch Drugs (India) Ltd	847 Cr.	242	268/117	28.2	80.0	0.00 %	13.4 %	10.6 %	10.0
Anuh Pharma Ltd	820 Cr.	81.6	99.5/66.7	18.6	35.1	1.83 %	14.9 %	10.7 %	5.00
Bafna Pharmaceuticals Ltd	973 Cr.	418	425/94.8	125	40.6	0.00 %	11.9 %	12.3 %	10.0
Themis Medicare Ltd	995 Cr.	109	141/65.0		43.3	0.46 %	2.74 %	0.41 %	1.00
Wanbury Ltd	687 Cr.	196	360/162	16.0	18.1	0.00 %	36.6 %	76.5 %	10.0
Industry Average	17,127.26 Cr	1,216.62		53.25	211.24	0.40%	26.16%	16.59%	6.06

All Competitor Stocks of Kilitch Drugs (India) Ltd

FINANCIALS

Quarterly performance

Compare sales, expenses, operating profit and net profit on one chart, across the same reporting quarters.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

Metric	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	36.56	41.20	31.79	44.82	33.45	47.47	56.17	61.23	43.14	48.92	53.81	89.60	44.88
Expenses	30.38	32.58	29.51	37.74	31.79	41.37	47.44	46.64	39.88	43.88	47.66	67.46	41.94
Operating Profit	6.18	8.62	2.28	7.08	1.66	6.10	8.73	14.59	3.26	5.04	6.15	22.14	2.94
OPM %	16.90%	20.92%	7.17%	15.80%	4.96%	12.85%	15.54%	23.83%	7.56%	10.30%	11.43%	24.71%	6.55%
Other Income	0.56	0.49	2.96	0.47	2.57	5.16	1.73	1.70	2.56	6.66	1.53	0.49	2.90
Interest	1.50	1.51	1.60	1.32	1.73	0.31	1.40	1.60	1.53	1.44	1.15	1.44	0.88
Depreciation	0.71	0.82	0.81	0.93	0.85	0.61	0.81	0.85	0.84	0.86	0.94	0.98	1.09
Profit before tax	4.53	6.78	2.83	5.30	1.65	10.34	8.25	13.84	3.45	9.40	5.59	20.21	3.87
Tax %	32.67%	24.93%	38.16%	30.57%	93.33%	16.73%	32.00%	26.23%	34.49%	14.47%	22.90%	26.37%	48.84%
Net Profit	3.06	5.09	1.74	3.68	0.11	8.61	5.61	10.22	2.27	8.04	4.31	14.88	1.96
EPS in Rs	0.99	1.35	0.83	1.03	0.38	2.46	1.70	2.97	0.87	2.34	1.27	4.15	0.83

Last Updated: September 29, 2026, 7:28 pm

FINANCIALS

Annual performance

Compare sales, expenses, operating profit and net profit across financial years. Trailing figures remain in the table.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: October 9, 2026, 8:57 pm

Metric	Mar 2012	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	108	19	21	27	51	82	53	68	114	140	154	198	235	237
Expenses	95	21	25	28	45	75	53	63	104	122	130	167	198	201
Operating Profit	13	-2	-4	-1	6	7	0	5	10	18	24	32	37	36
OPM %	12%	-9%	-19%	-2.0%	11%	9%	0.8%	8%	9%	13%	16%	16%	16%	15%
Other Income	92	3	2	1	3	4	4	3	3	3	4	11	11	12
Interest	3	0	0	0	0	1	1	1	1	5	6	5	6	5
Depreciation	5	2	10	10	2	2	2	2	2	4	3	3	4	4
Profit before tax	97	-1	-12	-9	6	9	2	5	10	12	19	34	39	39
Tax %	22%	-70%	-4%	-5%	16%	55%	48%	27%	35%	31%	30%	28%	24%
Net Profit	76	-0	-11	-9	5	4	1	4	6	8	14	25	30	29
EPS in Rs	52.99	-0.10	-3.89	-3.09	1.72	1.15	0.25	1.09	2.17	3.08	4.17	7.63	8.63	8.59
Dividend Payout %	52%	-0%	-0%	-0%	13%	20%	-0%	-0%	-0%	-0%	-0%	-0%	-0%

YoY Net Profit Growth

Year	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025	2025-2026
YoY Net Profit Growth (%)	18.18%	155.56%	-20.00%	-75.00%	300.00%	50.00%	33.33%	75.00%	78.57%	20.00%
Change in YoY Net Profit Growth (%)	0.00%	137.37%	-175.56%	-55.00%	375.00%	-250.00%	-16.67%	41.67%	3.57%	-58.57%

Kilitch Drugs (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2016-2017 to 2025-2026.

Growth

Compounded Sales Growth
10 Years:	26%
5 Years:	30%
3 Years:	20%
TTM:	38%

Compounded Profit Growth
10 Years:	43%
5 Years:	164%
3 Years:	60%
TTM:	123%

Stock Price CAGR
10 Years:	28%
5 Years:	33%
3 Years:	30%
1 Year:	9%

Return on Equity
10 Years:	4%
5 Years:	8%
3 Years:	10%
Last Year:	14%

Last Updated: September 5, 2025, 9:05 am

FINANCIALS

Balance sheet

Compare reserves and borrowings across the same financial years. Reserves are an accounting balance, not available cash.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: October 9, 2026, 8:57 pm

Month	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	13	13	13	14	15	15	15	16	16	16	16	35
Reserves	107	95	88	98	106	103	112	124	136	160	186	245
Borrowings	-0	0	1	1	9	13	15	20	22	32	49	89
Other Liabilities	7	8	11	15	13	12	61	50	46	32	61	89
Total Liabilities	127	117	113	128	144	143	203	210	220	240	313	458
Fixed Assets	9	42	33	33	32	32	30	65	64	62	64	67
CWIP	-0	-0	1	3	20	30	65	3	4	6	47	140
Investments	72	49	53	56	53	52	60	71	62	72	72	75
Other Assets	46	25	26	35	38	30	47	71	90	100	129	176
Total Assets	127	117	113	128	144	143	203	210	220	240	313	458

FINANCIALS

Cash generation

Compare operating cash and free cash flow across reported periods. Negative values remain visible.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

Month	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity +	-8	17	1	1	0	4	46	6	3	-2	18	24
Cash from Investing Activity +	-31	-20	-2	-4	-14	-10	-38	-15	8	-8	-40	-100
Cash from Financing Activity +	-0	0	-0	6	17	1	2	7	-1	9	13	82
Net Cash Flow	-39	-2	-0	2	3	-5	10	-2	10	-1	-9	6
Free Cash Flow	-10	-26	-0	-2	-19	-6	9	-2	-1	-8	-29	-76
CFO/OP	430%	-442%	-202%	25%	60%	1,598%	877%	79%	39%	23%	82%	92%

Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
Period	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Free Cash Flow	-10.00	-26.00	0.00	-2.00	-19.00	-6.00	9.00	-2.00	-1.00	-8.00	-29.00	-76.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Financial efficiency feed. Source: www.screener.in. The source URL identifies consolidated accounts. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Compare collection, inventory, payment and working-capital cycles together in days. Returns on capital and equity follow in a separate percentage chart.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Returns on capital & equity

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

Month	Mar 2012	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	51	243	286	196	148	86	109	122	132	142	149	156
Inventory Days	12	124	110	84	39	36	70	35	28	10	18	53
Days Payable	19	124	154	184	108	33	89	525	239	200	118	189
Cash Conversion Cycle	44	243	241	96	79	89	89	-367	-79	-48	50	20
Working Capital Days	-143	197	234	115	93	37	22	-223	-40	-4	30	56
ROCE %	8%		-10%	-9%	5%	6%	1%	3%	6%	10%	13%	16%

FINANCIALS

Ownership trends

Compare ownership groups across the same reporting dates. Shareholder counts appear separately below.

Shareholding comparison

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

Month	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	69.23%	69.23%	69.23%	69.23%	69.23%	69.23%	69.23%	69.23%	63.77%	63.77%	63.77%	63.77%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.12%
Public	30.78%	30.76%	30.77%	30.77%	30.77%	30.76%	30.77%	30.77%	36.22%	36.23%	36.22%	36.11%
No. of Shareholders	9,002	9,062	9,525	9,620	9,920	10,139	9,749	10,379	10,929	12,043	11,785	12,627

This stock is not held by any mutual fund.

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

Month	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	16.60	9.17	6.71	4.73	2.37
Diluted EPS (Rs.)	16.60	9.17	6.71	4.73	2.37
Cash EPS (Rs.)	17.44	10.52	7.59	5.57	3.71
Book Value[Excl.RevalReserv]/Share (Rs.)	125.81	109.62	96.64	90.03	83.56
Book Value[Incl.RevalReserv]/Share (Rs.)	125.81	109.62	96.64	90.03	83.56
Revenue From Operations / Share (Rs.)	123.31	95.99	89.59	73.31	44.22
PBDIT / Share (Rs.)	26.50	17.80	13.15	8.52	5.07
PBIT / Share (Rs.)	24.57	15.72	10.87	6.94	3.79
PBT / Share (Rs.)	21.44	12.03	7.71	6.17	3.30
Net Profit / Share (Rs.)	15.51	8.44	5.32	3.99	2.43
NP After MI And SOA / Share (Rs.)	16.60	9.08	6.71	4.73	2.37
PBDIT Margin (%)	21.49	18.54	14.67	11.62	11.47
PBIT Margin (%)	19.92	16.37	12.12	9.46	8.57
PBT Margin (%)	17.38	12.53	8.60	8.41	7.47
Net Profit Margin (%)	12.57	8.79	5.93	5.43	5.49
NP After MI And SOA Margin (%)	13.46	9.45	7.48	6.44	5.35
Return on Networth / Equity (%)	13.19	8.28	6.89	5.29	2.88
Return on Capital Employeed (%)	17.29	14.37	11.24	7.69	4.52
Return On Assets (%)	8.53	6.08	4.75	3.51	1.80
Long Term Debt / Equity (X)	0.13	0.00	0.00	0.00	0.00
Total Debt / Equity (X)	0.24	0.17	0.14	0.14	0.11
Asset Turnover Ratio (%)	0.71	0.67	0.65	0.48	0.41
Current Ratio (X)	2.06	2.27	1.84	1.65	1.10
Quick Ratio (X)	1.88	2.21	1.81	1.57	1.05
Inventory Turnover Ratio (X)	20.55	51.18	21.16	14.04	8.31
Interest Coverage Ratio (X)	8.46	4.83	4.16	11.08	10.42
Interest Coverage Ratio (Post Tax) (X)	5.95	3.29	2.68	6.18	5.99
Enterprise Value (Cr.)	619.00	638.35	218.65	272.89	130.24
EV / Net Operating Revenue (X)	3.12	4.14	1.57	2.39	1.90
EV / EBITDA (X)	14.52	22.29	10.67	20.55	16.57
MarketCap / Net Operating Revenue (X)	2.93	4.06	1.56	2.29	1.83
Price / BV (X)	2.87	3.56	1.43	1.88	0.98
Price / Net Operating Revenue (X)	2.93	4.06	1.56	2.29	1.83
EarningsYield	0.04	0.02	0.04	0.02	0.02